ECMT Hydrogel: Advanced Wound Care

Flowable and Ready to Use

Regulatory Stage
Clinical team

Flowable, ready-to-use ECM hydrogel designed for the management of partial and full-thickness wounds, including pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds, trauma wounds, and tunneling or undermined wounds and draining wounds.

ECM hydrogel provides mechanical support and maintains wound hydration. The material provides a viscous and cushioning barrier to cover and protect wounds from the surrounding environment.

Mimicking the native ECM environment, the ECM Hydrogel has properties comparable to the human skin suitable for tissue homeostasis and wound management.

Key Features

  • Proprietary ECM formulation
  • Ready-to-use — no mixing required
  • Conforms to irregular, tunneling, and undermined wound structures
  • Completely fills deep wounds

MBV: Ocular Program

Non-Clinical Stage
Eye care research

Matrix bound nanovesicles are a biologic therapy in development for treatment of corneal disease caused by post-procedural healing, dry eye disease, or environmental damage.

Therapeutic Approach

  • Matrix Bound Nanovesicles deliver targeted healing signals
  • Supports epithelial restoration and migration
  • Eye drop formulation for ease of use
  • Post-procedure recovery and chronic conditions

Future Indications

Our ECM platform enables expansion into additional areas where tissue regeneration and functional restoration are needed.